Dissertation > Excellent graduate degree dissertation topics show

Effect of Gastric Bypass on the Blood Glucose Level in Type 2 Diabetes Rat Model

Author: WuBo
Tutor: YinJiaJun
School: Zunyi Medical College,
Course: Surgery
Keywords: gastric bypass type 2 diabetes mellitus glucagons-like peptide-1
CLC: R587.1
Type: Master's thesis
Year: 2011
Downloads: 4
Quote: 0
Read: Download Dissertation


Background:More and more research prove that the gastric bypass operation on type 2 diabetic rats have an significant effection,surgical treatment on diabetes were accepted by more people, but we still do not know the mechanism of the surgical treatment.And we need to explore the true.Objective:To study the hypoglycemic effect of Gastric bypass(GBP) in streptozotocin (STZ)and high-glucose-high-fat diet-induced rat model of type 2 diabetes and evaluate the role of glucagon-like peptide-1, weight loss and decreased food intake after operation.Methods:twenty-four male SD diabetic rats induced by STZ and high-glucose-high-fat diet were randomly allocated into four groups:GBP(group O), shame operation(group S), food restriction (group F) and controls (group C). Plasma glucose concentration, insulin, glucagon-like peptide 1 (GLP-1) were measured respectively at fasting and postprandial condition before and the 1st week,2nd week,3rd week,4th week,8th week after GBP in all rats, weight and food intake were measured simultaneity.Results:Three weeks after operation in the GBP rats, mean fasting plasma glucose concentration declined from (16.7±3.7)mmol/L to (13.1±3.4)mmol/L and postprandial plasma glucose from (31.7±6.1)mmol/L to (17.2±3.3)mmol/L (P<0.05), fasting plasma insulin concentration rose from (28.55±8.26)IU/L to (46.37±10.32)IU/L and±postprandial plasma insulin from (30.62±8.88)IU/L to (51.23±11.34)IU/L (P<0.01), fasting plasma GLP-1 concentration rose from(7.11±2.21)pmol/L to (25.25±7.21)pmol/L (P<0.01) and postprandial plasma GLP-1 from (42.11±11.25)pmol/L to (97.72±30.12)pmol/L (P<0.01), and marked change happened four weeks after GBP.These results were not seen in the group S despite similar same postoperative weight gain profile. GBP resulted in better glycemic control than greater weight loss from food restriction.Conclusion:GBP can markedly reduce plasma glucose in type 2 diabetic rats, and hypoglycemic effect may owe to more GLP-1 secreted after GBP. The effects are not secondarily to weight loss or lower food intake after operation.

Related Dissertations

  1. Relationship between Level of Serum Uric Acid and Lower Extremity Arterial Disease in Patients with Type 2 Diabetes Mellitus,R587.1
  2. Efficacy and Safety of Biphasic Insulin Aspart 30 Once-daily Treatment in Patients with Type 2 Diabetes,R587.1
  3. The Blood Glucose Control and Influencing Factors in Type 2 Diabetic Patients with Oral Hypoglycemic Agents,R587.1
  4. Association of Genetic Variation of UTS2 Gene with Type2 Diabetes Mellitus and Hypertension,R587.1
  5. Relationship between Postprandial Blood Pressure and Lower Extremity Arterial Disease in Patients with Type 2 Diabetes Mellitus,R587.1
  6. The Comparison of Therapeutic Effect and Security between CSⅡ and MDI in Type 2 Diabetes Mellitus,R587.1
  7. The Characteristics of Coronary Angiography in Type 2 Diabetes Mellitus Patients with Suspected Coronary Artery Disease,R587.1
  8. Effect of Whey Protein on Improving Insulin Resistance and the Underlying Mechanisms,R587.1
  9. The Changes of T Lymphocyte Subsets and Costimulatory Molecules Before and After Shuxuetong Treatment in Type 2 Diabetes Subjects with Diabetic Kidney Disease,R692
  10. 50 Cases of Type 2 Diabetic Patients Serum Trace Element and Vitamin Change Analysis,R587.1
  11. Correlation Studies of Plasma Fatty Acids and Type 2 Diabetes Mellitus: Case Control Study,R587.1
  12. Risk Factors and Their Interaction of Type 2 Diabetes Mellitus among Rural Residents in Wang Cheng,R587.1
  13. Effects of New Intravenous Infusions on Blood Glucose Variability in Elderly Type 2 Diabetic Patients,R587.1
  14. Clinical Observation on the Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of 234 Patients with Type 2 Diabetic,R587.1
  15. Expression of Chemerin in Liver of Diet Induced Type 2 Diabetic Rats with IL-6 Intervention,R587.1
  16. Influence of Rosiglitazone on Both Bone Mineral Bensity and the Expression of BMP-2 and Bcl-xL in Osteoblast in OLETF Rats,R587.1
  17. Huanglianjiedu Tonga flavor particles combined basal insulin , metformin onset obesity, type 2 diabetes clinical observation,R587.1
  18. Study on Association of Urine NGAL with MAU in Type 2 Diabetes Mellitus,R587.1
  19. GAD-Ab, ICA, IAA in LADA Expression and Clinical Significance,R587.1
  20. The Association between Pigment Epithelium-Derived Factor and Urinary Albumin Excretion Rate in Type 2 Diabetes Mellitus,R587.1

CLC: > Medicine, health > Internal Medicine > Endocrine diseases and metabolic diseases > Islet disease > Diabetes
© 2012 www.DissertationTopic.Net  Mobile